Kidney Transplant Market Expected to Achieve 5.2% CAGR by 2029: Growth Forecast Insights

Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts.

How Large Will the Kidney Transplant Market Size By 2025?
In the past few years, the market size for kidney transplants has seen a stable increment. It is set to expand from $6.15 billion in 2024 to $6.44 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 4.6%. Factors contributing to this growth historically include research and clinical trials, patient education and support, improved diagnostic instruments, progress in after-transplant care, and immunosuppressive treatments.

How Big Is the Kidney Transplant Market Size Expected to Grow by 2029?
The market for kidney transplants is predicted to experience significant growth in the coming years, with its value expected to reach "$7.89 billion by 2029, growing at a compound annual growth rate (CAGR) of 5.2%. This predicted growth for the forecast period is highly driven by an upsurge in transplantation demands, progress in immunomodulatory therapies, an enlarged pool of living donors, reduction in wait times, and the role of telemedicine in pre-transplant assessments. Key emerging trends projected for this period involve patient-focused care systems, advancements in xenotransplantation research, superior rejection tracking, the utilization of telemedicine for aftercare post-transplants, and broadly extended access to transplantation.

View the full report here:
https://www.thebusinessresearchcompany.com/report/kidney-transplant-global-market-report

Which Key Market Drivers Powering Kidney Transplant Market Expansion and Growth?
The increasing prevalence of renal diseases and kidney failure is predicted to boost the kidney transplant market's expansion. Renal disease and kidney failure occur when the kidneys cease to function, failing to regulate bodily chemicals or eliminate waste and excess water from the bloodstream. Kidney transplants, which restore kidney functions and treat the root causes of renal failure, are necessary in such cases. For example, the American Kidney Fund, a non-profit organization based in the United States, stated that 37 million Americans were affected by kidney disease in 2023. Consequently, the escalating rates of renal diseases and kidney failure are fueling the kidney transplant market's growth.

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=10707&type=smp

Which Fast-Growing Trends Are Poised to Disrupt the Kidney Transplant Market?
The kidney transplant market is witnessing progress through innovations like dual immune/solid organ transplant. In June 2022, Stanford Medicine introduced DISOT for pediatric kidney transplants, transferring the donor's immune system to the recipient to eliminate the need for lifelong immunosuppressive drugs and reduce associated health risks.

What Are the Emerging Segments in the Kidney Transplant Market?
The kidney transplant market covered in this report is segmented -

1) By Transplant Type: Deceased-Donor Kidney Transplant, Living-Donor Kidney Transplant, Expanded Criteria Donor
2) By Age Group: Adult, Pediatrics
3) By Application: Drug Delivery, Capsule Endoscopy, Patient Monitoring
4) By End-User: Transplant Centers, Hospitals, Academic And Research Institutes

Subsegments:
1) By Deceased-Donor Kidney Transplant: Standard Criteria Donor, Extended Criteria Donor
2) By Living-Donor Kidney Transplant: Related Living Donor, Unrelated Living Donor, Paired Kidney Exchange
3) By Expanded Criteria Donor: Older Donors, Donors With Hypertension, Donors With Kidney Disease History

Tailor your insights and customize the full report here:
https://www.thebusinessresearchcompany.com/customise?id=10707&type=smp

Who Are the Global Leaders in the Kidney Transplant Market?
Major companies operating in the kidney transplant market include Pfizer Inc., Novartis AG, B. Braun Melsungen AG, Fresenius Medical Care AG & Co., Medtronic Plc., TransMedics Inc., Preservation Solution Inc., Organ Recovery Systems Inc., Transonic Systems Inc., DaVita Inc., Glycorex Transplantation AB, Astellas Pharma Inc., Veloxis Pharmaceuticals A/s, Immucor Inc., Penn Medicine, Sanofi S.A, Amgen Inc., Amyndas Pharmaceuticals, Abbvie Inc., Teva Pharmaceuticals Ltd., BiolifeSolutions, Bristol-Myers Squibb Company, CareDx Inc., CSL Behring, Grifols S.A., Kedrion Biopharma Inc.

Which are the Top Profitable Regional Markets for the Kidney Transplant Industry?
North America was the largest region in the kidney transplant market in 2024.Europe is expected to be the fastest-growing region in the global kidney transplant market report during the forecast period. The regions covered in the kidney transplant market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase the full report today:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10707

This Report Supports:
1. Business Leaders & Investors - To identify growth opportunities, assess risks, and guide strategic decisions.
2. Manufacturers & Suppliers - To understand market trends, customer demand, and competitive positioning.
3. Policy Makers & Regulators - To track industry developments and align regulatory frameworks.
4. Consultants & Analysts - To support market entry, expansion strategies, and client advisory work.

UC24_fI0rV8cR5DxlCpgmyFQ

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 7882 955267,
Asia: +91 88972 63534,
Americas: +1 310-496-7795 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.